Cancer research. As questions grow, Duke halts trials, launches investigation.
Couzin-Frankel
Jennifer
J
D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D035843:Biomedical Research / Q000592:standards*; D045744:Cell Line, Tumor; D002986:Clinical Trials as Topic; D020869:Gene Expression Profiling; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D009657:North Carolina; D010506:Periodicals as Topic; D010597:Pharmacogenetics; D011643:Publishing; D014495:Universities
D000970:Antineoplastic Agents